Enjoy complimentary customisation on priority with our Enterprise License!
The biopharmaceutical analytical testing services market size is forecast to increase by USD 3.45 billion between 2022 and 2027, accelerating at a CAGR of 12.61%. In 2017, US held the largest market share, projecting an annual revenue of USD 620.2 billion. The report includes a comprehensive outlook on the Biopharmaceutical Analytical Testing Services Market, offering forecasts for the industry segmented by Service, which comprises Bioanalytical, Method development and validation, Stability testing, and Others. Additionally, it categorizes End-User into Pharma, biotech companies, and CROs and covers Geography regions, including North America, APAC, Europe, South America, and Middle East and Africa. The report provides market size, historical data spanning from 2017 to 2021, and future projections, all presented in terms of value in (USD Billion/billion) for each of the mentioned segments.
To learn more about this report, Download Report Sample
The increase in demand for mAbs is notably driving the biopharmaceutical analytical testing services market growth. mAbs are proteins developed in pharmaceutical and biotechnology laboratories to bind to the corresponding epitope of the antigen in the body. These antibodies are used as independent treatments or in combination with radiotherapy, drugs, or toxins to exterminate the infected cells.
The global mAbs market is growing, as mAbs are used for immunotherapy to stimulate immune responses to treat diseases. The rise in demand for personalized medicine is a major factor behind this demand. mAbs are subjected to several quality control tests such as microbial tests, sterility tests, and dissolution tests to ensure their quality. Biopharmaceutical analytical testing services include product-related impurities information, structural characterization, and structural confirmation. Thus, the rise in demand for mAbs will increase the demand for analytical testing services, which, in turn, will fuel the growth of the healthcare analytical testing services market during the forecast period.
The market share growth by the bioanalytical segment will be significant during the forecast period and was valued at USD 858.00 Billion in 2017 and will continue to grow by 2021. Some of the major applications of bioanalytical testing techniques include bioavailability, pharmacology, bioequivalence, pharmacokinetic, and toxicology studies on humans and animals. The growth of this segment is expected to be driven by factors such as an increase in the use of biosimilars for a variety of medical indications, especially diabetes and cancer. Most contract research organizations (CROs), pharmaceutical companies, and bioanalytical laboratories are expanding their bioanalytical services and are investing in bioanalytical testing laboratories. Another driver for the growth of this segment is the outsourcing of R&D activities by pharmaceutical companies so that they can concentrate on their core competencies. New product development and innovation are expected to further increase the demand for bioanalytical testing services. This, in turn, is expected to expand the growth of the bioanalytical segment in the global biopharmaceutical analytical testing services market during the forecast period.
North America is estimated to contribute 33% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. North America has key companies such as Charles River and Catalent, which is driving the growth of the market. These companies have a diversified portfolio of analytical testing services, covering aspects of drug discovery, development, and manufacturing. The drugs need to be tested analytically according to the regulations to ensure safety, quality, and efficacy. The US and Canada are the key countries in the region, as stable economies and strong infrastructural support the launch of new drugs or biopharmaceuticals. High investments in R&D are further increasing the demand for high-quality analytical services in these countries. The rising prevalence of several diseases is increasing investments in clinical trials and research studies in the region. These factors are expected to drive the growth of the market in the region during the forecast period.
To understand geographic trends Download Report Sample
The Biopharmaceutical Analytical Testing Services Market is fragmented in nature. Some significant players include Almac Group Ltd.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Boston Analytical, Catalent Inc., Charles River Laboratories International Inc., Coriolis Pharma Research GmbH, Curia Inc., Element Materials Technology Group Ltd., Eurofins Scientific SE, ICON plc, Intertek Group Plc, Laboratory Corp. of America Holdings, Merck KGaA, Pace Analytical Services LLC, Parexel International Corp., SGS SA, Solvias AG, STERIS Plc, Thermo Fisher Scientific Inc., Vimta Labs Ltd., and West Pharmaceutical Services Inc.
The biopharmaceutical analytical testing services market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 - 2027.
|
Biopharmaceutical Analytical Testing Services Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
171 |
|
Base year |
2022 |
|
Historic period |
2017 - 2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 12.61% |
|
Market growth 2023-2027 |
USD 3.45 billion |
|
Market structure |
Fragmented |
|
YoY growth 2022-2023(%) |
11.67 |
|
Regional analysis |
North America, APAC, Europe, South America, and Middle East and Africa |
|
Performing market contribution |
North America at 33% |
|
Key countries |
US, China, Japan, UK, and Germany |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Almac Group Ltd., Boston Analytical, Catalent Inc., Charles River Laboratories International Inc., Coriolis Pharma Research GmbH, Curia Inc., Element Materials Technology Group Ltd., Eurofins Scientific SE, ICON plc, Intertek Group Plc, Laboratory Corp. of America Holdings, Merck KGaA, Pace Analytical Services LLC, Parexel International Corp., SGS SA, Solvias AG, STERIS Plc, Thermo Fisher Scientific Inc., Vimta Labs Ltd., and West Pharmaceutical Services Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Service
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Get the report (PDF) sent to your email within minutes.
